|
시장보고서
상품코드
2024658
체외수정(IVF)용 기기 및 소모품 시장 보고서 : 제품별, 기술별, 최종사용자별, 지역별(2026-2034년)IVF Devices and Consumables Market Report by Product, Technology, End User, and Region 2026-2034 |
||||||
세계의 체외수정(IVF)용 기기 및 소모품 시장 규모는 2025년에 34억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 93억 달러에 달하며, 2026-2034년에 CAGR 11.63%로 성장할 것으로 예측하고 있습니다.
체외수정(IVF)은 불임 치료를 돕고 유전적 문제를 예방하며 임신을 돕는 보조생식술(ART)의 일종입니다. 여기에는 배란, 채란, 수정, 수정, 배아 배양 및 이식을 위한 여러 가지 약물 및 수술 절차가 포함됩니다. 또한 난관이 막히거나 손상된 여성에게도 성공적인 임신과 건강한 아기의 탄생을 돕습니다. 또한 수정을 위해 세포질내 정자 주입법(ICSI)을 사용하여 남성 불임 문제를 해결합니다. 현재 전 세계에서 불임율이 증가함에 따라 기구, 액세서리, 일회용 제품, 시약, 배지 등 IVF용 기기 및 소모품의 이용이 증가하고 있습니다.
체외수정(IVF) 장비 및 소모품 시장 동향:
성공적인 임신을 위한 체외수정(IVF) 장비 및 소모품의 장점에 대한 대중의 인식이 높아짐에 따라 시장 성장을 이끄는 주요 요인 중 하나가 되고 있습니다. 이와 더불어 전 세계에서 임신 지연이 증가하고 있습니다. 이는 급성장하는 의료 산업과 맞물려 시장 성장에 기여하고 있습니다. 또한 원하는 부모가 자녀를 가질 수 있도록 돕는 정자 및 난자 제공의 증가는 업계 투자자들에게 매력적인 성장 기회를 제공하고 있습니다. 또한 많은 국가에서 정부가 의료 인프라에 많은 투자를 하고 있으며, 이는 시장에 긍정적인 영향을 미치고 있습니다. 이 외에도 주요 시장 기업은 배아 배양, 냉동 보존 및 체외 성숙 기술 향상을 위한 연구개발(R&D) 활동에 자금을 지원하고 있습니다. 또한 고객 기반을 확대하기 위한 다양한 마케팅 전략에도 주력하고 있습니다. 또한 배아 선별을 위한 체외수정(IVF)에 인공지능(AI)이 도입되면서 시장 성장을 촉진하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 체외수정(IVF)용 기기 및 소모품 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porters Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.05.18The global IVF devices and consumables market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2034, exhibiting a growth rate (CAGR) of 11.63% during 2026-2034.
In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ovulation, egg retrieval, insemination and fertilization, and embryo culture and transfer. It also helps in achieving a successful pregnancy and healthy baby in women with blocked or damaged fallopian tubes. In addition, it aids in male infertility problems by using intra-cytoplasmic sperm injection (ICSI) for conceiving. At present, there is a rise in the utilization of IVF devices and consumables, such as instruments, accessories and disposable, and reagents and media, on account of the increasing rate of infertility across the globe.
IVF DEVICES AND CONSUMABLES MARKET TRENDS:
The rising awareness among the masses about the benefits of using IVF devices and consumables for a successful pregnancy represents one of the key factors propelling the market growth. Besides this, there is an increase in the number of delayed pregnancies worldwide. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, the rising number of gamete donations around the world to help intended parents have a child is offering lucrative growth opportunities to industry investors. In addition, governments of several countries are extensively investing in healthcare infrastructures, which is positively influencing the market. Apart from this, key market players are financing research and development (R&D) activities for improving embryo culture and cryopreservation and in vitro maturation. They are also focusing on several marketing strategies to increase their customer base. Additionally, the integration of artificial intelligence (AI) in IVF for the identification of an embryo is bolstering the growth of the market.
KEY MARKET SEGMENTATION:
Breakup by Product:
- Instruments
- Sperm Separation Systems
- Cryosystems
- Incubators
- Imaging Systems
- Ovum Aspiration Pumps
- Cabinets
- Micromanipulators
- Others
- Accessories and Disposables
- Reagents and Media
- Cryopreservation Media
- Semen Processing Media
- Ovum Processing Media
- Embryo Culture Media
Breakup by Technology:
- Fresh Embryo IVF
- Frozen Embryo IVF
- Donor Egg IVF
Breakup by End User:
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report provides a comprehensive analysis of the competitive landscape in the global IVF devices and consumables market with detailed profiles of all major companies, including:
- Coopersurgical Inc.
- Genea BIOMEDX
- Hamilton Thorne
- InterMedics Healthcare LLP
- Kitazato Corporation
- LabIVF APAC Pte Ltd
- Memmert GmbH + Co.KG
- Nidacon International AB
- Rocket Medical
- Thermo Fisher Scientific Inc.
- Vitrolife
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global IVF Devices and Consumables Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Sperm Separation Systems
- 6.1.2.2 Cryosystems
- 6.1.2.3 Incubators
- 6.1.2.4 Imaging Systems
- 6.1.2.5 Ovum Aspiration Pumps
- 6.1.2.6 Cabinets
- 6.1.2.7 Micromanipulators
- 6.1.2.8 Others
- 6.1.3 Market Forecast
- 6.2 Accessories and Disposables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Reagents and Media
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Cryopreservation Media
- 6.3.2.2 Semen Processing Media
- 6.3.2.3 Ovum Processing Media
- 6.3.2.4 Embryo Culture Media
- 6.3.3 Market Forecast
7 Market Breakup by Technology
- 7.1 Fresh Embryo IVF
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Frozen Embryo IVF
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Donor Egg IVF
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End User
- 8.1 Fertility Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Hospitals
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Clinical Research Institutes
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Coopersurgical Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Genea BIOMEDX
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Hamilton Thorne
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 InterMedics Healthcare LLP
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Kitazato Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 LabIVF APAC Pte Ltd
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Memmert GmbH + Co.KG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Nidacon International AB
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Rocket Medical
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Thermo Fisher Scientific Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Vitrolife
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.1 Coopersurgical Inc.
